This work was supported by the grants from the National Natural Science Foundation of China (81572480 and 81172401, to M.L.) and the Second Affiliated Hospital of Soochow University Youth pre-Research Fund (SDFEYQN1607, to L.S.).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2017]版：
大类|2 区医学
小类|2 区肿瘤学3 区细胞生物学
最新[2023]版：
无
第一作者：
第一作者机构：[1]The Experimental Center, Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
通讯作者：
通讯机构：[1]The Experimental Center, Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
推荐引用方式(GB/T 7714)：
Lili Sun,Qing Lan,Ming Li.Targeting FHL2 for EGFRvIII-positive glioblastoma.[J].Oncotarget.2018,9(95):36730-36731.doi:10.18632/oncotarget.26422.
APA：
Lili Sun,Qing Lan&Ming Li.(2018).Targeting FHL2 for EGFRvIII-positive glioblastoma..Oncotarget,9,(95)
MLA：
Lili Sun,et al."Targeting FHL2 for EGFRvIII-positive glioblastoma.".Oncotarget 9..95(2018):36730-36731
